Literature DB >> 17999637

Generation of natural killer cells from serum-free, expanded human umbilical cord blood CD34+ cells.

I-Ting Kao1, Chao-Ling Yao, Zwe-Ling Kong, Mei-Ling Wu, Tzu-Lin Chuang, Shiaw-Min Hwang.   

Abstract

Natural killer (NK) cells are important effectors of the innate immune system, which exhibits cytolytic activity against infectious agents and tumor cells. NK cells are derived from CD34(+) hematopoietic stem cells (HSCs). Human umbilical cord blood (UCB) has been recognized as a rich source of HSCs. Previously, we have reported an optimized serum-free medium for ex vivo expansion of CD34(+) cells from UCB. In this study, the serum-free, expanded CD34(+) cells were tested to differentiate into NK cells and their induction kinetics. After 5 weeks of induction, the induced NK cells were characterized by analysis of surface antigens, IFN-gamma secretion, and cytotoxicity against K562 cells. The results indicated that NK cells derived from the serum-free, expanded CD34(+) cells exhibited both characteristics and functions of NK cells. Furthermore, the serum-free, expanded CD34(+) cells showed a significantly higher NK cell differentiation potential than freshly isolated CD34(+) cells. NK cells induced from serum-free, expanded CD34(+) cells showed a higher concentration of IFN-gamma secretion and ability of cytotoxicity than those from freshly isolated CD34(+) cells. Therefore, ex vivo-expanded CD34(+) cells in optimized serum-free medium could differentiate into NK cells and provided a promising cell source for immunotherapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999637     DOI: 10.1089/scd.2007.0033

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  18 in total

Review 1.  Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.

Authors:  Martha Luevano; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

2.  Expression of CD94 by ex vivo-differentiated NK cells correlates with the in vitro and in vivo acquisition of cytotoxic features.

Authors:  Meriem Hasmim; Nadine Khalife; Yanyan Zhang; Manale Doldur; Geralidne Visentin; Stéphane Terry; Julien Giron-Michel; Ruoping Tang; François Delhommeau; Nicolas Dulphy; Jean-Henri Bourhis; Fawzia Louache; Salem Chouaib
Journal:  Oncoimmunology       Date:  2017-07-18       Impact factor: 8.110

3.  Combined IL-15 and IL-12 drives the generation of CD34+-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer.

Authors:  Jeannette Cany; Anniek B van der Waart; Jan Spanholtz; Marleen Tordoir; Joop H Jansen; Robbert van der Voort; Nicolaas M Schaap; Harry Dolstra
Journal:  Oncoimmunology       Date:  2015-04-01       Impact factor: 8.110

4.  Lymphoid regeneration from gene-corrected SCID-X1 subject-derived iPSCs.

Authors:  Tushar Menon; Amy L Firth; Deirdre D Scripture-Adams; Zoran Galic; Susan J Qualls; William B Gilmore; Eugene Ke; Oded Singer; Leif S Anderson; Alexander R Bornzin; Ian E Alexander; Jerome A Zack; Inder M Verma
Journal:  Cell Stem Cell       Date:  2015-03-12       Impact factor: 24.633

5.  Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy.

Authors:  Yin Liu; Hong-Wei Wu; Michael A Sheard; Richard Sposto; Srinivas S Somanchi; Laurence J N Cooper; Dean A Lee; Robert C Seeger
Journal:  Clin Cancer Res       Date:  2013-02-01       Impact factor: 12.531

Review 6.  NK cell-based immunotherapy for malignant diseases.

Authors:  Min Cheng; Yongyan Chen; Weihua Xiao; Rui Sun; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-04-22       Impact factor: 11.530

7.  Tumor immunotherapy: New aspects of natural killer cells.

Authors:  Yangxi Li; Rui Sun
Journal:  Chin J Cancer Res       Date:  2018-04       Impact factor: 5.087

Review 8.  Understanding of molecular mechanisms in natural killer cell therapy.

Authors:  Suk Ran Yoon; Tae-Don Kim; Inpyo Choi
Journal:  Exp Mol Med       Date:  2015-02-13       Impact factor: 8.718

9.  High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.

Authors:  Jan Spanholtz; Marleen Tordoir; Diana Eissens; Frank Preijers; Arnold van der Meer; Irma Joosten; Nicolaas Schaap; Theo M de Witte; Harry Dolstra
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

10.  Overcoming the UCB HSCs -Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling Pathways.

Authors:  Alireza Shokouhifar; Gholamreza Anani Sarab; Mahboubeh Yazdanifar; Mohammad Fereidouni; Masoumeh Nouri; Marzieh Ebrahimi
Journal:  Cancer Cell Int       Date:  2021-06-07       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.